TY - JOUR
T1 - BRCA1 deficiency specific base substitution mutagenesis is dependent on translesion synthesis and regulated by 53BP1
AU - Chen, Dan
AU - Gervai, Judit Z.
AU - Póti, Ádám
AU - Németh, Eszter
AU - Szeltner, Zoltán
AU - Szikriszt, Bernadett
AU - Gyüre, Zsolt
AU - Zámborszky, Judit
AU - Ceccon, Marta
AU - d’Adda di Fagagna, Fabrizio
AU - Szallasi, Zoltan
AU - Richardson, Andrea L.
AU - Szüts, Dávid
N1 - Funding Information:
This work was supported by the National Research, Technology and Innovation Fund of Hungary (K_124881, FIEK_16-1-2016-0005 and VEKOP-2.3.3-15-2017-00014 to D.S., NAP2-2017-1.2.1-NKP-0002 to Z.Sza.), the Breast Cancer Research Foundation (BCRF-20-137 to A.L.R. and DS, BCRF-20-159 to Z.Sza.), Kræftens Bekæmpelse (R281-A16566 to Z.Sza.), the Novo Nordisk Foundation Interdisciplinary Synergy Programme Grant (NNF15OC0016584 to Z.Sza.), Department of Defense through the Prostate Cancer Research Program (W81XWH-18-2-0056 to Z.Sza.), Det Frie Forskningsråd Sundhed og Sygdom (7016-00345B to Z.Sza.), and the Basser Foundation (to Z.Sza.). A.L.R. is supported by the Peter and Judy Kovler Professorship in Breast Cancer Research. F.d’A.d.F laboratory is supported by: ERC advanced grant (TELORNAGING—835103); AIRC-IG (21762); Telethon (GGP17111); AIRC 5×1000 (21091); ERC PoC grant (FIREQUENCER—875139); Progetti di Ricerca di Interesse Nazionale (PRIN) 2015 “ATR and ATM-mediated control of chromosome integrity and cell plasticity”; Progetti di Ricerca di Interesse Nazionale (PRIN) 2017 “RNA and genome Instability”; Progetto AriSLA 2021 “DDR & ALS”; POR FESR 2014-2020 Regione Lombardia (InterSLA project); FRRB - Fondazione Regionale per la Ricerca Bio-medica - under the frame of EJP RD, the European Joint Programme on Rare Diseases with funding from the European Union’s Horizon 2020 research and innovation programme under the EJP RD COFUND-EJP No 825575.
Publisher Copyright:
© 2022, The Author(s).
PY - 2022/12
Y1 - 2022/12
N2 - Defects in BRCA1, BRCA2 and other genes of the homology-dependent DNA repair (HR) pathway cause an elevated rate of mutagenesis, eliciting specific mutation patterns including COSMIC signature SBS3. Using genome sequencing of knock-out cell lines we show that Y family translesion synthesis (TLS) polymerases contribute to the spontaneous generation of base substitution and short insertion/deletion mutations in BRCA1 deficient cells, and that TLS on DNA adducts is increased in BRCA1 and BRCA2 mutants. The inactivation of 53BP1 in BRCA1 mutant cells markedly reduces TLS-specific mutagenesis, and rescues the deficiency of template switch–mediated gene conversions in the immunoglobulin V locus of BRCA1 mutant chicken DT40 cells. 53BP1 also promotes TLS in human cellular extracts in vitro. Our results show that HR deficiency–specific mutagenesis is largely caused by TLS, and suggest a function for 53BP1 in regulating the choice between TLS and error-free template switching in replicative DNA damage bypass.
AB - Defects in BRCA1, BRCA2 and other genes of the homology-dependent DNA repair (HR) pathway cause an elevated rate of mutagenesis, eliciting specific mutation patterns including COSMIC signature SBS3. Using genome sequencing of knock-out cell lines we show that Y family translesion synthesis (TLS) polymerases contribute to the spontaneous generation of base substitution and short insertion/deletion mutations in BRCA1 deficient cells, and that TLS on DNA adducts is increased in BRCA1 and BRCA2 mutants. The inactivation of 53BP1 in BRCA1 mutant cells markedly reduces TLS-specific mutagenesis, and rescues the deficiency of template switch–mediated gene conversions in the immunoglobulin V locus of BRCA1 mutant chicken DT40 cells. 53BP1 also promotes TLS in human cellular extracts in vitro. Our results show that HR deficiency–specific mutagenesis is largely caused by TLS, and suggest a function for 53BP1 in regulating the choice between TLS and error-free template switching in replicative DNA damage bypass.
UR - http://www.scopus.com/inward/record.url?scp=85122824984&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85122824984&partnerID=8YFLogxK
U2 - 10.1038/s41467-021-27872-7
DO - 10.1038/s41467-021-27872-7
M3 - Article
C2 - 35017534
AN - SCOPUS:85122824984
SN - 2041-1723
VL - 13
JO - Nature Communications
JF - Nature Communications
IS - 1
M1 - 226
ER -